Yukihiro Shiga, Topcon Corporation (F);
Kazuki Hashimoto, None;
Kota Sato, Daiichi Sankyo Co., Ltd. (F), Japan Tobacco Inc. (F), Kowa Pharmaceutical Co., Ltd. (F), ROHTO Pharmaceutical Co., Ltd. (F), Santen Pharmaceutical Co., Ltd. (F), Senju Pharmaceutical Co., Ltd. (F), Topcon Corporation (F), Wakamoto Co., Ltd. (F);
Koji Nishiguchi, Santen Pharmaceutical Co., Ltd. (F), SENJU Pharmaceutical Co.,Ltd (F), Wakamoto Co., Ltd. (F);
Toru Nakazawa, Alcon Japan Ltd. (F), Daiichi Sankyo Co., Ltd. (F), Japan Tobacco Inc. (F), Kowa Company, Ltd. (F), Nidek CO., LTD. (F), Otsuka Pharmaceutical Co., Ltd. (F), ROHTO Pharmaceutical Co., Ltd. (F), Santen Pharmaceutical Co., Ltd. (F), SENJU Pharmaceutical Co.,Ltd (F), Topcon Corporation. (F), WAKAMOTO PHARMACEUTICAL CO., LTD. (F)